Arvinas Inc. Stock News

BidaskClub upgraded shares of Arvinas (NASDAQ:ARVN) from a buy rating to a strong-buy rating in a research report sent to investors on Tuesday, BidAskClub reports. A number of other research analysts

Chicago Equity Partners LLC trimmed its stake in Arvinas Inc (NASDAQ:ARVN) by 50.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission.

Barclays PLC decreased its holdings in shares of Arvinas Inc (NASDAQ:ARVN) by 23.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange

Advisory Research Inc. decreased its holdings in shares of Arvinas Inc (NASDAQ:ARVN) by 18.4% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 31,002 shares

American International Group Inc. increased its holdings in Arvinas Inc (NASDAQ:ARVN) by 14.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & E

Fear mounts as investors brace for a viral outbreak in the US. Volatility to remain high as Covid-19 virus remains an unknown threat. Impact on earnings outlook

Arvinas (NASDAQ:ARVN) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a note issued to investors on Tuesday, Zacks.com reports. According to Zacks, “Arv

Arvinas Inc (NASDAQ:ARVN) was the target of a significant decrease in short interest in February. As of February 14th, there was short interest totalling 1,590,000 shares, a decrease of 25.4% from the

Wall Street analysts forecast that Arvinas Inc (NASDAQ:ARVN) will report earnings per share of ($0.56) for the current quarter, according to Zacks Investment Research. Four analysts have made estimate

Dokter Ketut Suryana, Sp.PD-KAI FINASIM konsultan pada klinik VCT Merpati RSUD Wangaya Denpasar mengajak masyarakat untuk mengenali prinsip Exit, Survive, ...

Zacks Investment Research downgraded shares of Arvinas (NASDAQ:ARVN) from a buy rating to a hold rating in a research note issued to investors on Thursday morning, Zacks.com reports. According to Zack

Arvinas Inc (NASDAQ:ARVN)’s stock price was down 6.3% during mid-day trading on Friday . The company traded as low as $49.25 and last traded at $51.05, approximately 761,299 shares traded hands duri

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 6) Acceleron Pharma Inc (NASDAQ: XLRN ) Alector Inc (N

The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 5.) Alector Inc (NASDAQ: ALEC ) (announced gr

Healthcare is entering a period where election cycle impact will grow. The Medicare for All healthcare plan will begin to get factored based on the success of t